NCT06013865View on ClinicalTrials.gov

Empagliflozin Treatment in Kidney Transplant Recipients

PHASE4RecruitingINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

April 5, 2024

Primary Completion Date

March 31, 2030

Study Completion Date

March 31, 2030

Conditions
Kidney TransplantChronic Kidney Disease
Interventions
DRUG

Empagliflozin

SGLT2 Inhibitor

Trial Locations (5)

15240

RECRUITING

VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh

60141-3030

NOT_YET_RECRUITING

Edward Hines Jr. VA Hospital, Hines, IL, Hines

52246-2292

RECRUITING

Iowa City VA Health Care System, Iowa City, IA, Iowa City

68105-1850

RECRUITING

Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha

37212-2637

RECRUITING

Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville

All Listed Sponsors
collaborator

Iowa City VA Health Care System

FED

collaborator

VA Pittsburgh Healthcare System

FED

collaborator

VA Tennessee Valley Health Care System

FED

collaborator

VA Hines Health Care

UNKNOWN

lead

VA Office of Research and Development

FED